GroupAccess > Drug Coverage Guidelines

You are not signed in.

myBlueCross for Members
Forgot Username?
Forgot Password?

New to GroupAccess?

 

Search by Drug Name

  

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Product Name Implementation Date Guideline
COMBIVIR 07/01/12 The limits are 2 tablets per day.
COMBUNOX® 05/01/05 The limits are 120 tablets per 30 days.
COMETRIQ® 04/01/13 Prior authorization for medical necessity is required. The limits are 1 kit/28 days.
COMPLERA 07/01/12 The limits are 1 tablet per day.
COMPOUNDS 01/01/00 Prior authorization for medical necessity may be required.
CONCERTA® 11/01/02 The limits are 2 tablets per day.
CONZIP® 01/01/12 The limits are 30 capsules per 30 days.
COPAXONE® 10/01/12 The limits are 1 carton of 30 syringes per 30 days.
COSENTYX® 04/01/15 Cosentyx may be subject to step therapy requirements. Patients must have trial and failure of 2 preferred products. Preferred products are Humira, Enbrel, Stelara, and Simponi. Quantity limits apply based on package size.
COZAAR® 01/01/11 Cozaar may be subject to step therapy requirements. Patients must have trial and failure of both of the following: 1) generic ACE inhibitor or generic ARB, AND 2) preferred brand ARB (Diovan, Exforge/HCT, Micardis/HCT).
CRESTOR® 01/01/11 Crestor may be subject to step therapy requirements. Patients must have trial and failure of generic statin (lovastatin, pravastatin, simvastatin).
CRIXIVAN 07/01/12 The limits are 3 capsules per day for 100 mg, 9 capsules per day for 200 mg, and 6 capsules per day for 400 mg strengths.
CYMBALTA® 09/01/04 The limits are 2 capsules per day, except Cymbalta 60mg with a limit of 1 capsule per day.
DANAZOL 04/01/12 Prior authorization for medical necessity is required.
DAYTRANA® 06/12/06 The limits are 1 patch per day.

« Prev 6 7 8 9 10 Next »